Innoviva, Inc. (INVA)
NASDAQ·Healthcare·Biotechnology
$20.66
+0.19%
Mkt Cap $1.57B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (9 analysts)
$37.00
Range $32.00 – $42.00
Implied Upside
+79.1%
Consensus $37.00 vs current $20.66
NASDAQ·Healthcare·Biotechnology
$20.66
+0.19%
Mkt Cap $1.57B
Buy
5
Hold
0
Sell
0
Price Target (9 analysts)
$37.00
Range $32.00 – $42.00
+79.1%
Consensus $37.00 vs current $20.66